Thu, Jul 24, 2014, 11:25 AM EDT - U.S. Markets close in 4 hrs 35 mins

Recent

% | $
Click the to save as a favorite.

NovaBay Pharmaceuticals, Inc. Message Board

  • meliorist_man meliorist_man Jul 15, 2013 2:09 PM Flag

    Any idea?

    What news will be the next news? Will it be about urinary catheters? Will it be about viral conjunctivitis? Will it be about wound care?
    Any idea?
    Holding. Thinking of adding, but unsure of the wait time for results of one of the trials.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Urinary Catheter data due next month, Impetigo results due in October and the conjunctivitis results due in December . Expect good results so red chip can pump it even higher. Doubt red chip would start coverage on NBY right before all of their trial results failed it would cause chaos among their customers. I also doubt NBY would pay red chip a cash fee to promote them if they knew that they would lose investor support with failed data. This collaboration is a win/win for red chip and NBY. Red chip will look great with their amazing pick and receive cash: NBY will make their company stock more visible to the public, be able to execute share offerings at higher prices per share and be eligible for the bonus pool of 1 million dollars as per the 8k on April 24th. NBY and red chip know exactly what they are doing here so expect fireworks for 2013. I wish I could put a long-term sentiment disclosure of Extremely strong buy. GLTA

      Sentiment: Strong Buy

    • Got a brouchure in the mail today pushing NBY from Red. Says target price is over $4.00 and all the good atributes NBY has! So maybe you'll see some movement from the piece. Red is getting paid for it as it says in the small print. I'll watch. Bio's are high risk as we all know.

 
NBY
1.00+0.04(+4.06%)11:21 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.